Results 171 to 180 of about 133,046 (390)

Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis

Chest, 2017
J. Morisset, K. Johannson, E. Vittinghoff, C. Aravena, B. Elicker, K. Jones, C. Fell, H. Manganas, B. Dubé, P. Wolters, H. Collard, C. Ryerson, B. Ley   +12 more
semanticscholar   +1 more source

A Nascent Nasal Phenomenon

JEADV Clinical Practice, EarlyView.
Amy Long, Claire Quigley, Lisa Murphy, Niamh Leonard, Julianne Clowry   +4 more
wiley   +1 more source

Mycophenolate Facilitates Improvement in Outcome Measures in Treatment Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a potentially disabling autoimmune neuropathy. Approximately 20% of patients are refractory to first‐line treatments necessitating second‐line options with limited evidence and potential adverse effects.
Shamim Miah, Nicole Japzon, Amar Elsaddig, Shiwen Koay, Laura Compton, Michael P. Lunn, Aisling S. Carr   +6 more
wiley   +1 more source

Homotransplantation of the mitral valve in dogs treated with azathioprine

, 1968
Georg Papas, Jack L. Titus, F. Henry Ellis   +2 more
openalex   +1 more source

Measuring Adverse Event Burden in Myasthenia Gravis: Retrospective Validation of the Adverse Event Unit With Randomized Trial of Thymectomy in Myasthenia Gravis Data

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims The Adverse Event Unit (AEU) is a patient and physician weighted unit that quantifies and compares adverse event (AE) burden among any neurologic treatments. A recent study demonstrated feasibility and preliminary validity of the AEU in myasthenia gravis (MG).
Michael K. Hehir, Inmaculada B. Aban, Henry J. Kaminski   +2 more
wiley   +1 more source

Skin allograft survival in the thymectomised, azathioprine treated adult mongrel dog

, 1966
William A. Kisken
openalex   +1 more source

Trial comparing azathioprine and penicillamine in treatment of rheumatoid arthritis [proceedings]. [PDF]

, 1976
H Berry, S P Liyanage, R A Durance, C. G. Barnes, L. Berger   +4 more
openalex   +1 more source

MGBase: A Global, Observational Registry for Collaborative Research in Myasthenia Gravis

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Patient registries are valuable tools for outcomes research in rare diseases such as myasthenia gravis (MG). Existing MG registries are limited by factors including a lack of geographical scope. MGBase has been designed as a global, observational registry aimed at studying clinical practice outcomes in MG.
Katherine A. Buzzard, Anneke Van der Walt, Helmut Butzkueven, Wen Wen Zhang, Carolina Barnett‐Tapia, Gary Cutter, Jeannine M. Heckmann, Pamela Farr, Carolyn Tran, Charlotte Sartori, Dusko Stupar, Rein More, Linda Sim, Alison Le, Qingxiao Tang, Stephen W. Reddel, the MGBase Study Group, Stefan Blum, Gabvor Lovas, Pamela McCombe, Elisabeth Chroni, Belinda Cruse, Raed Alroughani, John Tzartos, Enrique Gomex‐Figueroa, Cavit Boz, Guntis Karelis, Allan Kermode, Nicholas Crump   +28 more
wiley   +1 more source

Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial. [PDF]

, 1976
H Berry, S P Liyanage, R A Durance, C. G. Barnes, L A Berger, Stephen J. Evans   +5 more
openalex   +1 more source

Role of neutrophils granularity intensity and reactive lymphocytes in assessing changes in lupus activity

Rheumatology &Autoimmunity, EarlyView.
Neut‐GI and Re‐Lymp levels correlated with changes in SLEDAl‐2K scores. Specifically, increasing in SLEDAl‐2K scores was associated with decreasing in extended inflammatory parameters. Thus, Neut‐Gland Re‐Lymp might serve as simpler and more cost‐effective alternatives to SLEDAI‐2K scores for monitoring changes in SLE activity.
Galuh Setyorini, Laniyati Hamijoyo, Evan Susandi, Delita Prihatni, Andri Iskandar Mardia, Amaylia Oehadian   +5 more
wiley   +1 more source